TY - JOUR
T1 - Effects of laparoscopic sleeve gastrectomy on weight loss and metabolic improvement in subjects aged 65 years or older
T2 - a subanalysis of J-SMART study
AU - Watanabe, Yasuhiro
AU - Yamaguchi, Takashi
AU - Sasaki, Akira
AU - Naitoh, Takeshi
AU - Matsubara, Hisahiro
AU - Yokote, Koutaro
AU - Okazumi, Shinichi
AU - Ugi, Satoshi
AU - Yamamoto, Hiroshi
AU - Ohta, Masayuki
AU - Ishigaki, Yasushi
AU - Kasama, Kazunori
AU - Seki, Yosuke
AU - Tsujino, Motoyoshi
AU - Shirai, Kohji
AU - Miyazaki, Yasuhiro
AU - Masaki, Takayuki
AU - Nagayama, Daiji
AU - Tatsuno, Ichiro
AU - Saiki, Atsuhito
N1 - Publisher Copyright:
© The Japan Diabetes Society 2024.
PY - 2025/1
Y1 - 2025/1
N2 - Aim: To investigate the effect of weight loss and metabolic improvement after laparoscopic sleeve gastrectomy (LSG) in older adults aged 65 years or over compared with younger adults in a retrospective analysis. Methods: The J-SMART study database of 322 Japanese individuals with body mass index (BMI) ≥32 kg/m2 who underwent LSG between 2011 and 2014 at 10 centers accredited by the Japanese Society for Treatment of Obesity were analyzed. The subjects were classified into two groups: ≥65 age group (range, 65–76 years; n = 25) and <65 age group (range, 22–64 years; n = 297). Clinical parameters were compared between the groups. Results: Baseline data for the ≥65 vs. <65 age groups were: median age 67 years vs. 45 years; weight 92.7 kg vs. 114.4 kg; BMI 40.0 kg/m2 vs. 41.9 kg/m2; and HbA1c 6.8% vs. 6.5%. The ≥65 age group had significantly lower preoperative weight, BMI, estimated glomerular filtration rate, and ABCD score, but higher visceral fat area and prevalence of diabetes, hypertension, and obstructive sleep apnea (OSAS). Weight was significantly reduced in both groups throughout 5 years post-LSG, though total weight loss at 2 years was lower in the ≥65 age group (28.0%) than in the <65 group (30.0%). Remission rates of diabetes, hypertension, OSAS, and joint disorders 2 years after LSG showed no significant differences, except for dyslipidemia. Conclusion: LSG may be an efficacious option for improving obesity-related health problems in older adults. However, postoperative safety and complications were not evaluated in this study and further research is needed.
AB - Aim: To investigate the effect of weight loss and metabolic improvement after laparoscopic sleeve gastrectomy (LSG) in older adults aged 65 years or over compared with younger adults in a retrospective analysis. Methods: The J-SMART study database of 322 Japanese individuals with body mass index (BMI) ≥32 kg/m2 who underwent LSG between 2011 and 2014 at 10 centers accredited by the Japanese Society for Treatment of Obesity were analyzed. The subjects were classified into two groups: ≥65 age group (range, 65–76 years; n = 25) and <65 age group (range, 22–64 years; n = 297). Clinical parameters were compared between the groups. Results: Baseline data for the ≥65 vs. <65 age groups were: median age 67 years vs. 45 years; weight 92.7 kg vs. 114.4 kg; BMI 40.0 kg/m2 vs. 41.9 kg/m2; and HbA1c 6.8% vs. 6.5%. The ≥65 age group had significantly lower preoperative weight, BMI, estimated glomerular filtration rate, and ABCD score, but higher visceral fat area and prevalence of diabetes, hypertension, and obstructive sleep apnea (OSAS). Weight was significantly reduced in both groups throughout 5 years post-LSG, though total weight loss at 2 years was lower in the ≥65 age group (28.0%) than in the <65 group (30.0%). Remission rates of diabetes, hypertension, OSAS, and joint disorders 2 years after LSG showed no significant differences, except for dyslipidemia. Conclusion: LSG may be an efficacious option for improving obesity-related health problems in older adults. However, postoperative safety and complications were not evaluated in this study and further research is needed.
KW - Diabetes
KW - Laparoscopic sleeve gastrectomy
KW - Obesity
KW - Older adults
UR - https://www.scopus.com/pages/publications/85206383494
U2 - 10.1007/s13340-024-00767-w
DO - 10.1007/s13340-024-00767-w
M3 - Article
AN - SCOPUS:85206383494
SN - 2190-1678
VL - 16
SP - 56
EP - 64
JO - Diabetology International
JF - Diabetology International
IS - 1
ER -